Arch Therapeutics, Inc. (ARTH) SEC filings
ARTH SEC filings moved a median of 0.00% by the close. ARTH SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ARTH overview →
45 measured ARTH SEC filing events.
Where these ARTH SEC filings landedvs 35 measured ARTH SEC filing reactions
| Middle 50% of ARTH SEC filing reactions | -3.46% to +1.61% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 35 |
Point-in-time · zero look-ahead
Half of the 35 ARTH SEC filing events with a measured close landed between -3.46% and +1.61%; 31% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Arch Therapeutics, Inc. | SEC filing · Form 15-12G | — | — | |
| Form 8-K Arch Therapeutics, Inc. For: Dec 29 | SEC filing · Form 8-K | — | — | |
| Form RW Arch Therapeutics, Inc. | SEC filing · Form RW | — | — | |
| Form 8-K Arch Therapeutics, Inc. For: Feb 03 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Arch Therapeutics, Inc. For: Jan 16 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form NT 10-K Arch Therapeutics, Inc. For: Sep 30 | SEC filing · Form NT | +0.00% | +0.00% | |
| Form 8-K Arch Therapeutics, Inc. For: Nov 04 | SEC filing · Form 8-K | — | — | |
| Form 8-K Arch Therapeutics, Inc. For: Oct 29 | SEC filing · Form 8-K | +0.00% | +4.43% | |
| Form 8-K Arch Therapeutics, Inc. For: Sep 20 | SEC filing · Form 8-K | +2.50% | +25.00% | |
| Form 8-K Arch Therapeutics, Inc. For: Sep 15 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Arch Therapeutics, Inc. For: Sep 13 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Arch Therapeutics, Inc. For: Aug 30 | SEC filing · Form 8-K | — | — | |
| Form 8-K Arch Therapeutics, Inc. For: Aug 20 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 10-Q Arch Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.92% | +1.92% | |
| Form 8-K Arch Therapeutics, Inc. For: Aug 14 | SEC filing · Form 8-K | — | — | |
| Form 8-K Arch Therapeutics, Inc. For: Aug 15 | SEC filing · Form 8-K | — | — | |
| Form NT 10-Q Arch Therapeutics, Inc. For: Jun 30 | SEC filing · Form NT | — | — | |
| Form 8-K Arch Therapeutics, Inc. For: Jul 29 | SEC filing · Form 8-K | — | — | |
| Form 8-K Arch Therapeutics, Inc. For: Jul 16 | SEC filing · Form 8-K | +0.00% | -8.57% | |
| Form 8-K Arch Therapeutics, Inc. For: Jun 30 | SEC filing · Form 8-K | +0.00% | +0.96% | |
| Form 8-K Arch Therapeutics, Inc. For: Jun 26 | SEC filing · Form 8-K | +10.84% | +10.84% | |
| Form 8-K Arch Therapeutics, Inc. For: Jun 19 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form S-1/A Arch Therapeutics, Inc. | SEC filing · Form S-1 | -3.29% | -10.80% | |
| Form 8-K Arch Therapeutics, Inc. For: Jun 12 | SEC filing · Form 8-K | -5.00% | +3.70% | |
| Form 8-K Arch Therapeutics, Inc. For: May 15 | SEC filing · Form 8-K | — | — | |
| Form 10-Q Arch Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.95% | |
| Form 8-K Arch Therapeutics, Inc. For: Apr 30 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Arch Therapeutics, Inc. For: Mar 28 | SEC filing · Form 8-K | -10.62% | -5.03% | |
| Form 8-K Arch Therapeutics, Inc. For: Mar 12 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 10-K/A Arch Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-K | -3.61% | -13.65% | |
| Form 8-K Arch Therapeutics, Inc. For: Feb 27 | SEC filing · Form 8-K | -3.61% | -13.65% | |
| Form 10-Q Arch Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-Q | -3.68% | -3.68% | |
| Form 10-K Arch Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-K | +15.25% | +1.70% | |
| Form NT 10-Q Arch Therapeutics, Inc. For: Dec 31 | SEC filing · Form NT | -5.84% | -3.25% | |
| Form 8-K Arch Therapeutics, Inc. For: Feb 01 | SEC filing · Form 8-K | +0.00% | +2.79% | |
| Form 8-K Arch Therapeutics, Inc. For: Jan 09 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Arch Therapeutics, Inc. For: Jan 05 | SEC filing · Form 8-K | +0.00% | +1.52% | |
| Form NT 10-K Arch Therapeutics, Inc. For: Sep 30 | SEC filing · Form NT | +0.15% | -2.29% | |
| Form 8-K Arch Therapeutics, Inc. For: Dec 13 | SEC filing · Form 8-K | +7.33% | +3.33% | |
| Form 8-K Arch Therapeutics, Inc. For: Dec 05 | SEC filing · Form 8-K | -1.61% | -26.20% | |
| Form 8-K Arch Therapeutics, Inc. For: Nov 29 | SEC filing · Form 8-K | -10.64% | +9.24% | |
| Form 8-K Arch Therapeutics, Inc. For: Nov 21 | SEC filing · Form 8-K | -0.59% | -17.52% | |
| Form 8-K Arch Therapeutics, Inc. For: Nov 08 | SEC filing · Form 8-K | +0.00% | -25.58% | |
| Form 8-K Arch Therapeutics, Inc. For: Nov 09 | SEC filing · Form 8-K | -12.50% | +0.00% | |
| Form S-1/A Arch Therapeutics, Inc. | SEC filing · Form S-1 | -12.50% | +0.00% |
Keep exploring
More ARTH: earnings → · analyst actions → · ARTH overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| FLUOROPHARMA MEDICAL INC (FPMI) | 55 | 0.00% | 37% |
| REMSLEEP HOLDINGS INC (RMSL) | 55 | 0.00% | 38% |
| Currenc Group Inc. - Ordinary Shares (CURR) | 53 | -0.35% | 44% |
| KAYA HOLDINGS INC (KAYS) | 53 | 0.00% | 25% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.